3 clinical trials led by STALICLA on portal of the World Health Organization (WHO) and ClinicalTrials.gov

STALICLA is now enrolling patients with ASD Phenotype 1 in the first interventional trial with STP1 in this biologically-defined subpopulation (NCT04644003).

STALICLA is also conducting two observational studies (NCT04600882 and NCT04273087) to identify new subgroups of patients within the autism spectrum.